Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Oncol Nurs Forum
; 40(6): 549-57, 2013 Nov.
Article
em En
| MEDLINE
| ID: mdl-24161633
ABSTRACT
PURPOSE/OBJECTIVES:
To estimate and compare responsiveness of standardized self-reported measures of musculoskeletal symptoms (MSSs) and physical functioning (PF) during treatment with aromatase inhibitors (AIs).DESIGN:
Prospective, longitudinal study.SETTING:
Park Nicollet Institute and North Memorial Cancer Center, both in Minneapolis, MN. SAMPLE 122 postmenopausal women with hormone receptor-positive breast cancer.METHODS:
MSSs and PF were assessed before starting AIs and at one, three, and six months using six self-reported MSSs measures and two PF tests. MAIN RESEARCH VARIABLES MSSs and PF changes from baseline to six months.FINDINGS:
Using the Breast Cancer Prevention Trial-Musculoskeletal Symptom (BCPT-MS) subscale, 54% of participants reported MSSs by six months. Scores from the BCPT-MS subscale and the physical function subscales of the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) and Western Ontario and McMaster Osteoarthritis Index (WOMAC) were most responsive to changes over six months.CONCLUSIONS:
BCPT-MS, AUSCAN, and WOMAC were the most responsive instruments for measuring AI-associated MSSs. IMPLICATIONS FOR NURSING Assessment and management of MSSs are important aspects of oncology care because MSSs can affect functional ability and AI adherence. KNOWLEDGE TRANSLATION The three measures with the greatest sensitivity were the BCPT-MS, AUSCAN, and WOMAC questionnaires. These measures will be useful when conducting research on change in MSSs associated with AI treatment in women with breast cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Índice de Gravidade de Doença
/
Neoplasias da Mama
/
Carcinoma Ductal de Mama
/
Artralgia
/
Debilidade Muscular
/
Antineoplásicos Hormonais
/
Inibidores da Aromatase
/
Limitação da Mobilidade
/
Estrogênios
/
Mialgia
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Oncol Nurs Forum
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Mongólia